Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
281,791
-
Share change
-
+231,178
-
Total reported value
-
$146,000
-
Price per share
-
$0.52
-
Number of holders
-
7
-
Value change
-
+$119,602
-
Number of buys
-
7
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2016
As of 31 Mar 2016 IGC Pharma, Inc. - COM NEW (IGC) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 281,791 shares of stock of the company.
Largest 7 holders included CITADEL ADVISORS LLC, KCG HOLDINGS, INC., SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES, LLC, UBS Group AG, Creative Planning, and Gradient Investments LLC.
This table shows 7 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.